Clinical trial
Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With…
NCT00345137 · Regional Hospital Holstebro, Other · Completed
Key facts
| NCT number | NCT00345137 |
|---|---|
| Title | Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis |
| Official title | Phase 1 Study of Systemic Effects of Ng-Monomethyl-L-Arginine on Renal Hemodynamics in Patients With Polycystic Kidney Disease and Chronic Glomerulonephritis |
| Lead sponsor | Regional Hospital Holstebro, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | ADPKD, Glomerulonephritis |
| Intervention type | Drug |
| Interventions | Ng-monomethyl-L-arginine (drug) |
| Enrollment | 75 |
| First posted | Jun 27, 2006 |
| Last update posted | Jun 27, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: